Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral Therapy
Top Cited Papers
Open Access
- 15 November 2010
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (10) , 1553-1561
- https://doi.org/10.1086/656722
Abstract
Background. The gut is a major reservoir for human immunodeficiency virus (HIV) in patients receiving antiretroviral therapy (ART). We hypothesized tKeywords
This publication has 42 references indexed in Scilit:
- Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performanceJournal of Virological Methods, 2010
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- Isolating Mucosal Lymphocytes from Biopsy Tissue for Cellular Immunology AssaysPublished by Springer Nature ,2009
- Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into LatencyJournal of Virology, 2008
- HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressorsAIDS, 2008
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral TherapyThe Journal of Infectious Diseases, 2008
- Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapyRetrovirology, 2008
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of TherapyThe Journal of Infectious Diseases, 2008
- Superantigen-induced CD4+ T cell tolerance is associated with DNA methylation and histone hypo-acetylation at cytokine gene lociGenes & Immunity, 2007
- Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infectionAIDS, 1999